BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tan T, Lawrance IC. Use of mycophenolate mofetil in inflammatory bowel disease. World J Gastroenterol 2009; 15(13): 1594-1599 [PMID: 19340901 DOI: 10.3748/wjg.15.1594]
URL: https://www.wjgnet.com/1007-9327/full/v15/i13/1594.htm
Number Citing Articles
1
Yezaz A Ghouri, Veysel Tahan, Bo Shen. Secondary causes of inflammatory bowel diseasesWorld Journal of Gastroenterology 2020; 26(28): 3998-4017 doi: 10.3748/wjg.v26.i28.3998
2
Antony Pan, Martin Schlup, Ralf Lubcke, Michael Schultz. Fulminant ulcerative colitis despite maximal immunosuppression following liver transplantation: A case report and literature reviewJournal of Crohn's and Colitis 2011; 5(5): 465 doi: 10.1016/j.crohns.2011.04.011
3
Brendan G. Dwyer, Chao Wang, Daniel Abegg, Brittney Racioppo, Nan Qiu, Zhensheng Zhao, Dany Pechalrieu, Anton Shuster, Dominic G. Hoch, Alexander Adibekian. Chemoproteomics‐Enabled De Novo Discovery of Photoswitchable Carboxylesterase Inhibitors for Optically Controlled Drug MetabolismAngewandte Chemie International Edition 2021; 60(6): 3071 doi: 10.1002/anie.202011163
4
Rossella Gioco, Daniela Corona, Burcin Ekser, Lidia Puzzo, Gaetano Inserra, Flavia Pinto, Chiara Schipa, Francesca Privitera, Pierfrancesco Veroux, Massimiliano Veroux. Gastrointestinal complications after kidney transplantationWorld Journal of Gastroenterology 2020; 26(38): 5797-5811 doi: 10.3748/wjg.v26.i38.5797
5
Matthew R. Smith, Sheldon C. Cooper. Mycophenolate mofetil therapy in the management of inflammatory bowel disease — A retrospective case series and reviewJournal of Crohn's and Colitis 2014; 8(8): 890 doi: 10.1016/j.crohns.2014.01.014
6
Eva-Marie Gram-Kampmann, Søren T Lillevang, Sönke Detlefsen, Stig Borbjerg Laursen. Wireless capsule endoscopy as a tool in diagnosing autoimmune enteropathyBMJ Case Reports 2015; : bcr2014207931 doi: 10.1136/bcr-2014-207931
7
Morris Gordon, Adrian G Thomas, Anthony K Akobeng. Mycophenolate mofetil for induction of remission in Crohn's diseaseCochrane Database of Systematic Reviews 2011;  doi: 10.1002/14651858.CD009123
8
Hamidreza Sohbati, Mohsen Amini, Saeed Balalaie. Synthesis and Biological Evaluation of Novel Anti-leukemia Proteolysis-Targeting Chimeras in Degradating Inosine Monophosphate DehydrogenaseIranian Journal of Pharmaceutical Research 2022; 21(1) doi: 10.5812/ijpr-129251
9
Fabio Salvatore Macaluso, Marcello Maida, Sara Renna, Emanuele Orlando, Marco Affronti, Chiara Sapienza, Mariangela Dimarco, Rosalba Orlando, Giulia Rizzuto, Mario Cottone, Ambrogio Orlando. Mycophenolate mofetil is a valid option in patients with inflammatory bowel disease resistant to TNF-α inhibitors and conventional immunosuppressantsDigestive and Liver Disease 2017; 49(2): 157 doi: 10.1016/j.dld.2016.10.001
10
Syed A. Rizvi. Clinical Neuroimmunology2011; : 131 doi: 10.1007/978-1-60327-860-7_7
11
Jeffrey Jacobs, Kindra Clark-Snustad, Scott Lee. Deep Remission in Severe Refractory Crohn’s Disease With Mycophenolate MofetilInflammatory Bowel Diseases 2023; 29(2): 332 doi: 10.1093/ibd/izac213
12
Sara Renna, Mario Cottone, Ambrogio Orlando. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel diseaseWorld Journal of Gastroenterology 2014; 20(29): 9675-9690 doi: 10.3748/wjg.v20.i29.9675
13
Syed A. Rizvi. Clinical NeuroimmunologyCurrent Clinical Neurology 2020; : 137 doi: 10.1007/978-3-030-24436-1_7
14
Johannes Söllner, Paul Mayer, Andreas Heinzel, Raul Fechete, Christian Siehs, Rainer Oberbauer, Bernd Mayer. Synthetic lethality for linking the mycophenolate mofetil mode of action with molecular disease and drug profilesMolecular BioSystems 2012; 8(12): 3197 doi: 10.1039/c2mb25256b
15
Jeffery M Venner, Charles N Bernstein. Immunomodulators: still having a role?Gastroenterology Report 2022; 10 doi: 10.1093/gastro/goac061
16
Scott M. Whitlock, Clinton W. Enos, April W. Armstrong, Alice Gottlieb, Richard G. Langley, Mark Lebwohl, Joseph F. Merola, Caitriona Ryan, Michael P. Siegel, Jeffrey M. Weinberg, Jashin J. Wu, Abby S. Van Voorhees. Management of psoriasis in patients with inflammatory bowel disease: From the Medical Board of the National Psoriasis FoundationJournal of the American Academy of Dermatology 2018; 78(2): 383 doi: 10.1016/j.jaad.2017.06.043
17
Kalle Landerholm, Disa Kalman, Conny Wallon, Pär Myrelid. Immunomodulators: Friends or Enemies in Surgery for Crohn’s Disease?Current Drug Targets 2019; 20(13): 1384 doi: 10.2174/1389450120666190617163919
18
Brendan G. Dwyer, Chao Wang, Daniel Abegg, Brittney Racioppo, Nan Qiu, Zhensheng Zhao, Dany Pechalrieu, Anton Shuster, Dominic G. Hoch, Alexander Adibekian. Chemoproteomics‐Enabled De Novo Discovery of Photoswitchable Carboxylesterase Inhibitors for Optically Controlled Drug MetabolismAngewandte Chemie 2021; 133(6): 3108 doi: 10.1002/ange.202011163
19
Matteo Tollemeto, Sintija Ursulska, Pascal L. W. Welzen, Lasse H. E. Thamdrup, Atena Malakpour‐Permlid, Yudong Li, Gohar Soufi, Tania Patiño Padial, Jørn B. Christensen, Line Hagner Nielsen, Jan van Hest, Anja Boisen. Tailored Polymersomes for Enhanced Oral Drug Delivery: pH‐Sensitive Systems for Intestinal Delivery of ImmunosuppressantsSmall 2024; 20(43) doi: 10.1002/smll.202403640
20
Ian C Lawrance. Early investigational TNF receptor antagonists for the treatment of ulcerative colitisExpert Opinion on Investigational Drugs 2015; 24(6): 761 doi: 10.1517/13543784.2015.1020371
21
Multiple drugsReactions Weekly 2021; 1853(1): 319 doi: 10.1007/s40278-021-95185-0
22
Ning Zhou, Wei-xing Chen, Shao-hua Chen, Cheng-fu Xu, You-ming Li. Inflammatory bowel disease unclassifiedJournal of Zhejiang University SCIENCE B 2011; 12(4): 280 doi: 10.1631/jzus.B1000172
23
P. Azevedo, C. Freitas, P. Aguiar, H. Silva, T. Santos, P. Farrajota, M. Almeida, S. Pedroso, L.S. Martins, L. Dias, R. Vizcaíno, A. Castro Henriques, A. Cabrita. A Case Series of De Novo Inflammatory Bowel Disease After Kidney TransplantationTransplantation Proceedings 2013; 45(3): 1084 doi: 10.1016/j.transproceed.2013.03.008
24
Jiayun M Fang, Laura Lamps, Amoah Yeboah-Korang, Jerome Cheng, Maria Westerhoff. De Novo Inflammatory Bowel Disease Rarely Occurs During Posttransplant ImmunosuppressionAmerican Journal of Clinical Pathology 2021; 156(6): 1113 doi: 10.1093/ajcp/aqab084
25
Michael Friedt, Christian P. Braegger. Pädiatrische Gastroenterologie, Hepatologie und Ernährung2013; : 333 doi: 10.1007/978-3-642-24710-1_11
26
A. Hernández-Camba, L. Arranz, I. Vera, D. Carpio, M. Calafat, A.J. Lucendo, C. Taxonera, S. Marín, M.J. Garcia, G. Suris Marín, E. Sánchez Rodríguez, A.Y. Carbajo, M.L. De Castro, M. Iborra, A. Martin-Cardona, I. Rodríguez-Lago, D. Busquets, F. Bertoletti, M. Sierra Ausín, C. Tardillo, J. Huguet Malaves, L. Bujanda, A. Castaño, E. Domènech, L. Ramos, O. Merino. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registryDigestive and Liver Disease 2022; 54(5): 635 doi: 10.1016/j.dld.2021.10.002
27
Marie-France Dubeau, Marietta Iacucci, Paul L. Beck, Gordon W. Moran, Gilaad G. Kaplan, Subrata Ghosh, Remo Panaccione. Drug-Induced Inflammatory Bowel Disease and IBD-Like ConditionsInflammatory Bowel Diseases 2013; 19(2): 445 doi: 10.1002/ibd.22990
28
KaranRajgopal Kalani, AnujAchyut Ban, Sumeet Singla. Co-existing ulcerative colitis and takayasu arteritis: A case-based reviewIndian Journal of Rheumatology 2022; 17(4): 416 doi: 10.4103/injr.injr_290_21